“…Increasing evidence has shown that targeting ROS/NADPH oxidase, NLRP3 inflammasome, MAPK/NF-κB signaling, Nrf2 signaling, autophagy, and mitochondrial bioenergetics provides potential therapeutic strategies for the prevention and treatment of various inflammatory diseases [ 15 , 137 , 138 , 139 , 140 , 141 , 142 ]. However, given the multifactorial etiology of inflammatory diseases and the limited success of antioxidant therapies achieved to date, therapeutic targets at single risk factor interventions are not enough to block the progression of inflammatory diseases.…”